Medical Cannabis for Autism Spectrum Disorder: Evidence, Access, and Risks
Medical cannabis is not FDA-approved for autism; evidence is low-certainty, though small CBD studies report gains in irritability and sleep.
Medical cannabis is not FDA-approved for autism; evidence is low-certainty, though small CBD studies report gains in irritability and sleep.
Learn about the potential use of cannabis in autism therapy, focusing on dosage considerations.
No single strain is proven for autism. See which high-CBD, low-THC strains people ask about, what the research shows, and how dosing works.
Cannabis and autism research studies are small and mostly open-label. Here is what trials show, the risks, and how convenience shapes product choice.
CBD may ease irritability and anxiety in some children with autism, but evidence is early, dosing is unclear, and doctors do not treat it as standard care.
Research does not confirm cannabis treats autism. Learn what small CBD studies show, the risks for children, legal rules, and better-evidenced options.
No cannabis oil is FDA-approved for autism in children. Trials are small. What studies and pediatric groups say about CBD, THC, and side effects.
A guide to filing cannabis rescheduling public comments, comparing the official federal docket, mailed submissions, form letters, and hearing testimony.
The cannabis rescheduling timeline follows federal rulemaking steps: HHS review, DEA proposed rule, public comment, hearings, and a final rule.
Rescheduling eases tax and banking rules but keeps cannabis controlled. Legalization removes federal prohibition. Here is which path to plan around.
Discover how the rescheduling of cannabis could affect prices and what you need to know before making a purchase.
The status of cannabis rescheduling in the US is currently under review, with no final decision made.
Stay informed about the latest developments in cannabis rescheduling with our comprehensive guide.
Federal rescheduling changes taxes and banking, not what your state store can sell. Judge products on lab testing, labeling, and local rules.
Cannabis Schedule III is a proposed federal classification, not current law. Here is what it means, what would change, and what stays the same.
The DEA hearing on cannabis rescheduling is a pivotal moment for the industry. Here's what you need to know.
Cannabis rescheduling stalled in 2024 after a DEA hearing and no final rule. What the Schedule III proposal would change for taxes, payments, and convenience.
Learn about the penalties for exceeding the cannabis possession limit in the U.S. and how to avoid them.
Discover the legal cannabis possession limits for minors in the United States and understand the consequences of exceeding these limits.
Discover the top-rated marijuana possession limit gram chart guide for 2023, including key criteria and expert analysis.